<DOC>
	<DOCNO>NCT01093547</DOCNO>
	<brief_summary>Phase IV post-marketing study evaluate effect Extraneal HOMA index non-diabetic CAPD patient long-dwell exchange . The purpose study investigate use Extraneal ( mixture high weight glucose polymer ) , instead glucose-based solution Dianeal go low HOMA index non-diabetic CAPD patient .</brief_summary>
	<brief_title>Open-label , Randomized Trial Determine Effect Icodextrin Versus Dextrose ( Dianeal 2.5 % ) HOMA IR</brief_title>
	<detailed_description />
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Icodextrin</mesh_term>
	<criteria>must 18years old 75years old Peritoneal Equilibration Test ( PET ) result high , high average low average transport nondiabetic patient Continuous Ambulatory Peritoneal Dialysis ( CAPD ) prevalent patient peritoneal dialysis least 30 day wish participate Have Charlson score &gt; 7 life expectancy le 12 month HIV positive present peritonitis month prior randomisation present cardiovascular , metabolic infection complication require hospitalisation month prior randomisation active cancer pregnant woman patient know allergy starchbased polymer patient significant psychiatric disorder mental disability could interfere patientÂ´s ability provide Informed Consent comply protocol procedure woman incapable maintain effective accepted contraception method</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>